According to Emergen Research, the global prenatal testing and newborn screening market size was USD 4,652.21 million in 2020 and is expected to reach USD 12.23 billion in 2028 and register a revenue CAGR of 12.8% during the forecast period, 2021-2028.
Emergen Research has published its latest report titled “Prenatal Testing and Newborn Screening Market, By Type (Prenatal Testing, Newborn Screening), By Test Type (Invasive, Non-invasive), By Technology (Mass Spectrometry, Electrophoresis, Enzyme Immunoassays, DNA Assays), By Instrument (Ultrasonography, Reagent and Assay Kits, Tandem Quadrupole Detector, Incubator Shaker, Hearing Screen Instruments), By End-use (Hospitals, Maternity & Specialty Clinics, Diagnostic Centers, Others), and By Region, Forecast to 2028”
According to Emergen Research, the global prenatal testing and newborn screening market size was USD 4,652.21 million in 2020 and is expected to reach USD 12.23 billion in 2028 and register a revenue CAGR of 12.8% during the forecast period, 2021-2028.
Market Dynamics:
The global prenatal testing and newborn screening market revenue growth is majorly attributed to factors such as increasing birth rates across the globe, rising prevalence of genetic or chromosomal defects and disorders, rising problems associated with increased maternal age, and growing demand for non-invasive prenatal testing (NIPT) and screening methods. Increasing awareness of early detection of genetic defects in infants, technological advancements in prenatal testing and newborn screening techniques in terms of improved chemistry, bioinformatics, and functionalities, and rising demand for NIPT procedures among pregnant women as a less painful alternative to procedures such as amniocentesis are among the other key factors boosting the global market revenue growth.
Furthermore, rapidly advancing global healthcare infrastructure and growing availability of favorable government reimbursement plans & policies for low-risk pregnancies are expected to further boost revenue growth of the global market. Market revenue growth, however, is hampered significantly by factors such as lack of awareness of prenatal testing, rising costs of prenatal testing and newborn screening procedures, and absence of proper healthcare infrastructure, especially in low-income countries around the world.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/346
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Non-invasive Segment Accounted for Largest Revenue Share in 2020:
Based on test type, the global prenatal testing and newborn screening market is segmented into invasive and non-invasive. The non-invasive segment accounted for the largest revenue share in the global market in 2020. Non-invasive testing offers several advantages over invasive prenatal testing for pregnant women, such as lowered risk of miscarriage, reduced blood loss reduced health complications in infants. Rising incidences of genetic disorders in newborn babies, such as the Down syndrome, Patau syndrome, and Edward syndrome, and growing demand for non-invasive prenatal testing and newborn screening methods for advantages such as lesser pain, faster recovery, decreased risks of infection, and shorter hospital stays are key factors driving this segment’s revenue growth.
Diagnostic Centers Segment to Account for Fastest Revenue CAGR:
Based on end-use, the global prenatal testing and newborn screening market is segmented into Hospitals, Maternity & Specialty Clinics, Diagnostic Centers, and Others. The diagnostic centers segment is expected to register the fastest revenue CAGR in the global market over the forecast period. Factors contributing to this segment’s revenue growth are rising cases of chromosomal anomalies and disorders, introduction of advanced prenatal testing and diagnostic methods, increasing volumes of prenatal testing & screening procedures, and presence of skilled healthcare professionals.
North America Accounted for Largest Revenue Share in 2020:
The North America prenatal testing and newborn screening market accounted for the largest revenue share in the global market in 2020. Increasing birth rates, rising cases of chromosomal defects and disorders in infants, increasing demand for non-invasive prenatal testing (NIPT), and rising awareness of early detection of chromosomal defects are key drivers for the North America market revenue growth. Increasing availability of technologically advanced diagnostic solutions and presence of state-of-the-art healthcare infrastructure in the region further boost the regional market growth.
Buy your Exclusive copy @ https://www.emergenresearch.com/select-license/346
Major Companies in the Global Prenatal Testing and Newborn Screening Market Include:
- Abbott Laboratories
- Bio-Rad Laboratories
- Color Genomics
- Edinburgh Genomics
- Eurofins Scientific
- Agilent Technologies
- Illumina Inc.
- Editas Medicine
- Qiagen NV
- PerkinElmer Inc.
- Progenity
- Natera Inc.
- Invitae
- Laboratory Corporation of America Holdings
For the purpose of this report, Emergen Research has segmented the global prenatal testing and newborn screening market based on type, test type, technology, instrument, end-use, and region:
Type Outlook (Revenue, USD Billion; 2018-2028)
- Prenatal Testing
- Newborn Screening
Test Type Outlook (Revenue, USD Billion; 2018-2028)
- Invasive
- Non-invasive
Technology Outlook (Revenue, USD Billion; 2018-2028)
- Mass Spectrometry
- Electrophoresis
- Enzyme Immunoassays
- DNA Assays
Instrument Outlook (Revenue, USD Billion; 2018-2028)
- Ultrasonography
- Reagent and Assay Kits
- Tandem Quadrupole Detector
- Incubator Shaker
- Hearing Screen Instruments
End-use Outlook (Revenue, USD Billion; 2018-2028)
- Hospitals
- Maternity & Specialty Clinics
- Diagnostic Centers
- Others
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/prenatal-testing-and-newborn-screening-market
Region Outlook (Revenue, USD Billion; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of Middle East & Africa
Explore Latest Published Blogs by Emergen Research:
Top 10 Leading Companies Offering Path-breaking Blockchain AI Solutions
Top 10 Companies in the AI-Enabled Medical Imaging Solutions Market
Top 10 IoT Medical Device Companies Leading the Digital Revolution in Healthcare
Top 7 Companies Offering Blockchain Technology In Energy Sector
World’s Top 10 Leading Companies Incorporating SLAM Technology to Offer Next-level Mapping and Location Tracking Solutions
Top 10 Companies in the World Providing Top-tier Edge Analytics Solutions
Top 10 Globally Leading Companies Offering Next-Generation Smart Factory Solutions
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-prenatal-testing-and-newborn-screening-market